Stock 1801 INNOVENT BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:07 2024-06-03 am EDT 		5-day change 1st Jan Change
34.4 HKD -2.27% Intraday chart for Innovent Biologics, Inc. -4.18% -19.53%
May. 28 Innovent Biologics, Inc. Announces Picankibart Achieved Primary Endpoints in A Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to the NDA to the NMPA CI
May. 21 Chinese Regulator Accepts Innovent Biologics' New Drug Application for Thyroid Eye Disease Drug MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Innovent Biologics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 10:00 AM
Transcript : Innovent Biologics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-15-2021
Transcript : Innovent Biologics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-15-2020 12:00 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1801 Stock
  4. News Innovent Biologics, Inc.
  5. Transcripts